As illustrated in Figure 3, PBMCs enhanced NF-κB transcriptional activity by about 1.4- and 2.2-fold in MCF-7 and MDA-MB-231 cells, respectively, compared to the breast cancer cells alone. The gene discussed is NFKB1; the disease is breast carcinoma.